Longitudinal assessment of pain management with the pain management index in cancer outpatients receiving chemotherapyReportar como inadecuado

Longitudinal assessment of pain management with the pain management index in cancer outpatients receiving chemotherapy - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

Supportive Care in Cancer

, Volume 25, Issue 3, pp 925–932

First Online: 16 November 2016Received: 24 May 2016Accepted: 01 November 2016DOI: 10.1007-s00520-016-3482-x

Cite this article as: Fujii, A., Yamada, Y., Takayama, K. et al. Support Care Cancer 2017 25: 925. doi:10.1007-s00520-016-3482-x


PurposeThe adequacy of pain management for individuals with cancer who receive outpatient chemotherapy is unclear. The primary objective of this study was to assess pain prevalence and intensity in such patients. The secondary objectives included assessment of pain management with the pain management index PMI and exploration of predictors of inadequate pain management.

MethodsCancer patients who received outpatient chemotherapy were enrolled. Patients were required to complete questionnaires covering demographic data and including the Brief Pain Inventory and the Distress Thermometer and Impact Thermometer. The PMI score was determined twice with an interval of at least 3 weeks.

ResultsOf the 740 patients enrolled in the study, 524 individuals 70.8% completed all questionnaires. Totals of 282 patients 53.8% and 264 patients 50.4% reported pain at baseline and follow-up, respectively, with ∼14% of patients having moderate or severe pain at each assessment. Totals of 365 patients 69.7% at baseline and 320 patients 61.1% at follow-up reported pain or were prescribed analgesics, with the rate of inadequate pain management for these patients being 39.7 and 51.6%, respectively. Multivariable analysis for 418 patients 79.8% who had pain or required analgesics at baseline or follow-up or both revealed that the most significant predictor of inadequate pain management was depressive state.

ConclusionsPain in cancer patients receiving outpatient chemotherapy is prevalent and at risk for undertreatment. Pain management should be assessed on a regular basis and is likely to be improved by screening for depression.

KeywordsCancer Pain Outpatient chemotherapy Pain management index PMI Inadequate pain management Depressive state  Download fulltext PDF

Autor: Akiko Fujii - Yu Yamada - Koichi Takayama - Takako Nakano - Junji Kishimoto - Tatsuya Morita - Yoichi Nakanishi

Fuente: https://link.springer.com/

Documentos relacionados